These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15968108

  • 1. An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors.
    Zannettino AC, Farrugia AN, To LB, Atkins GJ.
    Methods Mol Med; 2005; 113():245-56. PubMed ID: 15968108
    [Abstract] [Full Text] [Related]

  • 2. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
    Heath DJ, Vanderkerken K, Cheng X, Gallagher O, Prideaux M, Murali R, Croucher PI.
    Cancer Res; 2007 Jan 01; 67(1):202-8. PubMed ID: 17210700
    [Abstract] [Full Text] [Related]

  • 3. Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.
    Zannettino AC, Farrugia AN, Kortesidis A, Manavis J, To LB, Martin SK, Diamond P, Tamamura H, Lapidot T, Fujii N, Gronthos S.
    Cancer Res; 2005 Mar 01; 65(5):1700-9. PubMed ID: 15753365
    [Abstract] [Full Text] [Related]

  • 4. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M, Lucibello M, Vannier E, Fabiani S, Miliani A, Guidi G, Spada O, Dower SK, Sims JE, Shaw AR, Dinarello CA, Garaci E, Cozzolino F.
    Exp Hematol; 1996 Jul 01; 24(8):868-74. PubMed ID: 8690044
    [Abstract] [Full Text] [Related]

  • 5. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P.
    J Bone Miner Res; 2006 Feb 01; 21(2):193-206. PubMed ID: 16418775
    [Abstract] [Full Text] [Related]

  • 6. Bone-resorbing cells in multiple myeloma: osteoclasts, myeloma cell polykaryons, or both?
    Silvestris F, Ciavarella S, De Matteo M, Tucci M, Dammacco F.
    Oncologist; 2009 Mar 01; 14(3):264-75. PubMed ID: 19286760
    [Abstract] [Full Text] [Related]

  • 7. Osteoclast culture and resorption assays.
    Bradley EW, Oursler MJ.
    Methods Mol Biol; 2008 Mar 01; 455():19-35. PubMed ID: 18463808
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis of myeloma bone disease.
    Roodman GD.
    Blood Cells Mol Dis; 2004 Mar 01; 32(2):290-2. PubMed ID: 15003820
    [Abstract] [Full Text] [Related]

  • 9. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE, Wordsworth PB, Edwards JR, Ferguson DJ, Athanasou NA.
    Hum Pathol; 2006 Sep 01; 37(9):1176-85. PubMed ID: 16938523
    [Abstract] [Full Text] [Related]

  • 10. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
    Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N.
    Hum Pathol; 2005 Sep 01; 36(9):945-54. PubMed ID: 16153456
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of bone lesions in multiple myeloma.
    Bataille R, Chappard D, Klein B.
    Hematol Oncol Clin North Am; 1992 Apr 01; 6(2):285-95. PubMed ID: 1582975
    [Abstract] [Full Text] [Related]

  • 12. The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease.
    Brunetti G, Colucci S, Rizzi R, Mori G, Colaianni G, Oranger A, Zallone A, Liso V, Grano M.
    Ann N Y Acad Sci; 2006 Apr 01; 1068():334-40. PubMed ID: 16831934
    [Abstract] [Full Text] [Related]

  • 13. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ, Chang EJ, Kim HM, Lee SB, Kim HD, Su Kim G, Kim HH.
    Free Radic Biol Med; 2006 May 01; 40(9):1483-93. PubMed ID: 16632109
    [Abstract] [Full Text] [Related]

  • 14. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ.
    Cancer Res; 2005 Dec 01; 65(23):11001-9. PubMed ID: 16322249
    [Abstract] [Full Text] [Related]

  • 15. [Mechanisms for formation of myeloma bone disease].
    Yata K, Abe M, Matsumoto T.
    Clin Calcium; 2008 Apr 01; 18(4):438-46. PubMed ID: 18379024
    [Abstract] [Full Text] [Related]

  • 16. Characterization of in vitro growth of multiple myeloma cells.
    Zlei M, Egert S, Wider D, Ihorst G, Wäsch R, Engelhardt M.
    Exp Hematol; 2007 Oct 01; 35(10):1550-61. PubMed ID: 17889722
    [Abstract] [Full Text] [Related]

  • 17. Treatment strategies for bone disease.
    Roodman GD.
    Bone Marrow Transplant; 2007 Dec 01; 40(12):1139-46. PubMed ID: 17680018
    [Abstract] [Full Text] [Related]

  • 18. Synovial fluid macrophages are capable of osteoclast formation and resorption.
    Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ, Athanasou NA.
    J Pathol; 2006 Jan 01; 208(1):35-43. PubMed ID: 16278818
    [Abstract] [Full Text] [Related]

  • 19. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
    Nguyen AN, Stebbins EG, Henson M, O'Young G, Choi SJ, Quon D, Damm D, Reddy M, Ma JY, Haghnazari E, Kapoun AM, Medicherla S, Protter A, Schreiner GF, Kurihara N, Anderson J, Roodman GD, Navas TA, Higgins LS.
    Exp Cell Res; 2006 Jun 10; 312(10):1909-23. PubMed ID: 16600214
    [Abstract] [Full Text] [Related]

  • 20. Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients.
    Colucci S, Brunetti G, Mori G, Oranger A, Centonze M, Mori C, Cantatore FP, Tamma R, Rizzi R, Liso V, Zallone A, Grano M.
    Leukemia; 2009 Nov 10; 23(11):2139-46. PubMed ID: 19587706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.